In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
As of close of business last night, Genius Sports Limited’s stock clocked out at $10.03, up 0.20% from its previous closing price of $10.01. In other words, the price has increased by $0.20 from its previous closing price. On the day, 2.54 million shares were traded. GENI stock price reached its highest trading level at $10.2 during the session, while it also had its lowest trading level at $9.705.
Ratios:
To gain a deeper understanding of GENI’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 19.16 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 36.77. For the most recent quarter (mrq), Quick Ratio is recorded 1.42 and its Current Ratio is at 1.43. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
On March 18, 2025, Guggenheim started tracking the stock assigning a Buy rating and target price of $12.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 06 ’25 when Stevens Eric bought 79,373 shares for $9.38 per share.
Davison Jack bought 100,388 shares of GENI for $876,939 on Jan 17 ’25. On Jan 10 ’25, another insider, Davison Jack, who serves as the Officer of the company, bought 8,202 shares for $8.73 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GENI now has a Market Capitalization of 2334683136 and an Enterprise Value of 2000406784. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.07 while its Price-to-Book (P/B) ratio in mrq is 3.70. Its current Enterprise Value per Revenue stands at 3.916 whereas that against EBITDA is -78.083.
Stock Price History:
The Beta on a monthly basis for GENI is 1.98, which has changed by 0.7752212 over the last 52 weeks, in comparison to a change of 0.08089435 over the same period for the S&P500. Over the past 52 weeks, GENI has reached a high of $11.16, while it has fallen to a 52-week low of $4.91. The 50-Day Moving Average of the stock is 6.80%, while the 200-Day Moving Average is calculated to be 25.10%.
Shares Statistics:
It appears that GENI traded 3.22M shares on average per day over the past three months and 4753520 shares per day over the past ten days. A total of 239.82M shares are outstanding, with a floating share count of 216.07M. Insiders hold about 9.90% of the company’s shares, while institutions hold 76.58% stake in the company. Shares short for GENI as of 1741910400 were 31448933 with a Short Ratio of 9.76, compared to 1739491200 on 29193808. Therefore, it implies a Short% of Shares Outstanding of 31448933 and a Short% of Float of 14.81.
